Trial 3G-17-2


A Phase Ib/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Unresectable Or Metastatic Gastric Or Gastroesophageal Junction Cancer Or Esophageal Cancer (Morpheus Gastric And Esophageal Cancer)

Type: Treatment
Phase: Phase I/II
Status: Not Open (Closed)
Treatments: Biological Response Modifier, Chemotherapy: Systemic, Immunotherapy
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Syma Iqbal, M.D.
Other Trial Staff:  Ramona Lujan, Coordinator, Fahim Raian, D.M., Jiayi Jiang, D.M., Raluca Agafitei, Coordinator, Marile Garcia, Coordinator, Yanli Wang, D.M., Rabia Rehman, Coordinator, Diana Oganyesyan, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.